Highlights from the 25th National GEDO Day – Biomedicine Agency
Biomedicine Agency shared a post on LinkedIn:
“A look back at the Agency’s participation in the 25th National GEDO Day
The Biomedicine Agency is delighted to have been able to participate in this anniversary edition of the Study Group for Egg Donation (GEDO) around the common thread ‘Evidence and uncertaint'”.
During the workshop dedicated to regulatory aspects in oocyte donation and ovarian failure:
- Chloé Baron and Samuel Arrabal took a concrete look at the European SoHO regulation applied to multidisciplinary egg donation platforms.
- Dr. Claire de Vienne shared his vision on secondary egg donation in France, shedding light on the essential role of private centers in donation pathways.
Their interventions have fuelled debates, provoked reflections and strengthened our conviction: combining scientific rigour, ethics and solidarity is essential to advance biomedicine for the benefit of patients.
A big thank you to the GEDO and the organizers for their welcome, the quality of the exchanges and this strong moment of co-construction.
To find out more about egg donation.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 5, 2025, 10:35Amy Marsden: Vipoglanstat – A New Treatment for Endometriosis
-
Dec 5, 2025, 10:20Revolutionary Saliva Test Validated for Endometriosis – Femtech Insider
-
Dec 5, 2025, 10:07Silvia Vicenzi։ Endometriosis Research Shifts Focus to Immune Dysregulation
-
Dec 5, 2025, 09:26Revolutionizing Endometriosis Detection With miRNA Biomarkers – HerAnova Lifesciences
-
Dec 5, 2025, 08:59Kate Gunther: Rimegepant Shows Antiproliferative Effects in Endometriosis Models
-
Dec 5, 2025, 08:48Alycia Wells: Revolutionary ADHD Research Sheds Light on Women’s Brains
-
Dec 5, 2025, 08:40PFAS Exposure Disrupts Placental Development In Pregnancy – Medical Xpress
-
Dec 3, 2025, 16:10Exploring Future Strategies for Embryo Selection in IVF – Reproductive BioMedicine Online
-
Dec 3, 2025, 16:08Thorsten Waloschek: Addressing Risks in Pregnancies with Sclerosis